Return on Equity (ROE)
Updated 392h ago
Sector Performance
44th percentileELV
12.1%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
ELV’s current Return on Equity (ROE) of 12.1% means that for every dollar of shareholder equity, the company generated 12.1 cents in profit over the past 12 months — a measure of how efficiently it uses investors’ money.
This sits below the sector median of 13.8%, placing the company in the 44th percentile among its peers. The year-over-year change is unavailable, but the quarter-over-quarter change shows a 6.2% decline, from 12.9% to 12.1%. With ROE below the midpoint of the sector and a negative quarterly trend, there is a moderate risk that profitability relative to equity is weakening, though the decline is limited to a single quarter’s data. This performance does not contradict the overall NEUTRAL verdict; it aligns with a view that the stock offers no strong advantage or disadvantage on this metric given its below-median level and recent slip.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about ELV?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are ELV's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master ELV's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full ELV research report →ELV
12.1%
Sector Median
13.8%
Sector Avg
31.4%
How ELV's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.